Income Statement Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2026-03-06 pm EST			5-day change	1st Jan Change
115.79 ^USD	-0.24%		-6.49%	+10.00%

Mar. 06	Top pharma companies racing to launch a weight-loss pill	RE
Mar. 04	Health Rounds: Laser treatment before immunotherapy helps brain cancer patients live longer	RE

a95cc7997a5d.y4DtXU0YRkJg7oPOJXgyapE7PqJDn0rJSBA3TEJQN4c.j_S0aCJsdjYP29q3TxNBI_JudtUX8xytOHlbPBopXOmhyIQpKXwPBiKLuw

Published financial data: MERCK & CO., INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	48.7B	59.28B	60.12B	64.17B	65.01B
Total Revenues	48.7B	59.28B	60.12B	64.17B	65.01B
Cost of Goods Sold, Total	13.24B	17.21B	15.92B	14.7B	14.82B
Gross Profit	35.46B	42.08B	44.2B	49.47B	50.2B
Selling General & Admin Expenses, Total	9.4B	9.67B	9.88B	10.1B	10.12B
R&D Expenses	10.2B	11.84B	18.34B	14.48B	15.61B
Other Operating Expenses, Total	19.61B	21.51B	28.23B	24.58B	25.73B
Operating Income	15.86B	20.56B	15.97B	24.89B	24.47B
Interest Expense, Total	-806M	-962M	-1.15B	-1.27B	-1.36B
Interest And Investment Income	36M	314M	365M	415M	343M
Net Interest Expenses	-770M	-648M	-781M	-856M	-1.01B
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-297M	-237M	-370M	-227M	-323M
Other Non Operating Income (Expenses)	256M	524M	420M	290M	203M
EBT, Excl. Unusual Items	15.05B	20.2B	15.24B	24.1B	23.33B
Restructuring Charges	-868M	-666M	-933M	-888M	-2.55B
Merger & Related Restructuring Charges	-1.7B	-	-11.41B	-3.46B	-83M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	1.94B	-1.42B	340M	14M	368M
Asset Writedown	-275M	-1.6B	-779M	-	-
Legal Settlements	-	-	-573M	-	-
Other Unusual Items	-260M	-75M	-	170M	-
EBT, Incl. Unusual Items	13.88B	16.44B	1.89B	19.94B	21.07B
Income Tax Expense	1.52B	1.92B	1.51B	2.8B	2.8B
Earnings From Continuing Operations	12.36B	14.53B	377M	17.13B	18.26B
Earnings Of Discontinued Operations	704M	-	-	-	-
Net Income to Company	13.06B	14.53B	377M	17.13B	18.26B
Minority Interest	-13M	-7M	-12M	-16M	-9M
Net Income - (IS)	13.05B	14.52B	365M	17.12B	18.25B
Net Income to Common Incl Extra Items	13.05B	14.52B	365M	17.12B	18.25B
Net Income to Common Excl. Extra Items	12.34B	14.52B	365M	17.12B	18.25B
Per Share Items
Net EPS - Basic	5.16	5.73	0.14	6.76	7.3
Basic EPS - Continuing Operations	4.88	5.73	0.14	6.76	7.3
Basic Weighted Average Shares Outstanding	2.53B	2.53B	2.54B	2.53B	2.5B
Net EPS - Diluted	5.14	5.71	0.14	6.74	7.28
Diluted EPS - Continuing Operations	4.86	5.71	0.14	6.74	7.28
Diluted Weighted Average Shares Outstanding	2.54B	2.54B	2.55B	2.54B	2.51B
Normalized Basic EPS	3.71	4.98	3.75	5.94	5.82
Normalized Diluted EPS	3.7	4.96	3.74	5.92	5.81
Dividend Per Share	2.6	2.76	2.92	3.08	3.24
Payout Ratio	50.66	48.3	2.04K	45.8	44.79
American Depositary Receipts Ratio (ADR)	0.12	0.12	0.12	0.12	0.12
Supplemental Items
EBITDA	18.98B	24.35B	19.71B	29.13B	29.1B
EBITA	17.49B	22.65B	18.02B	27.28B	27.26B
EBIT	15.86B	20.56B	15.97B	24.89B	24.47B
EBITDAR	19.32B	24.69B	20.04B	29.48B	29.53B
Effective Tax Rate - (Ratio)	10.96	11.66	80.04	14.06	13.31
Current Domestic Taxes	61M	2.32B	976M	929M	403M
Current Foreign Taxes	1.27B	1.16B	2.44B	3.12B	4.07B
Total Current Taxes	1.33B	3.49B	3.41B	4.05B	4.48B
Deferred Domestic Taxes	264M	-1.64B	-1.67B	-1.46B	-1.59B
Deferred Foreign Taxes	-77M	71M	-233M	212M	-83M
Total Deferred Taxes	187M	-1.57B	-1.9B	-1.25B	-1.67B
Normalized Net Income	9.39B	12.62B	9.51B	15.04B	14.57B
Non-Cash Pension Expense	17M	-101M	-396M	-509M	-544M
Supplemental Operating Expense Items
Advertising Expense	2B	2.2B	2.3B	2.4B	2.3B
Selling and Marketing Expenses	2B	2.2B	2.3B	2.4B	2.3B
Research And Development Expense From Footnotes	12.24B	13.55B	30.53B	17.94B	15.79B
Net Rental Expense, Total	343M	334M	339M	348M	423M
Imputed Operating Lease Interest Expense	65M	77.17M	91.07M	94.94M	103M
Imputed Operating Lease Depreciation	278M	257M	248M	253M	320M
Stock-Based Comp., Other (Total)	479M	541M	645M	761M	820M
Total Stock-Based Compensation	479M	541M	645M	761M	820M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	8.1B	12.69B	6.84B	13.24B	14.56B
Short Term Investments	-	498M	252M	447M	-
Trading Asset Securities, Total	14M	-	-	-	-
Total Cash And Short Term Investments	8.11B	13.19B	7.09B	13.69B	14.56B
Accounts Receivable, Total	10.78B	10.62B	11.7B	11.12B	12.69B
Other Receivables	-	-	-	8M	15M
Total Receivables	10.78B	10.62B	11.7B	11.13B	12.71B
Inventory	5.95B	5.91B	6.36B	6.11B	6.66B
Restricted Cash	-	79M	68M	76M	125M
Other Current Assets, Total	5.42B	5.92B	6.94B	7.78B	9.46B
Total Current Assets	30.27B	35.72B	32.17B	38.78B	43.52B
Gross Property Plant And Equipment	39.06B	40.75B	42.75B	44.3B	48.74B
Accumulated Depreciation	-18.19B	-17.98B	-18.27B	-19.16B	-21.91B
Net Property Plant And Equipment	20.86B	22.77B	24.49B	25.15B	26.82B
Long-term Investments	966M	1.85B	1.56B	1.61B	2.08B
Goodwill	21.26B	21.2B	21.2B	21.67B	21.58B
Other Intangibles, Total	22.93B	20.27B	18.01B	16.37B	26.68B
Accounts Receivable Long-Term	-	-	-	-	125M
Deferred Tax Assets Long-Term	692M	503M	1.97B	3.6B	2.6B
Other Long-Term Assets, Total	8.71B	6.85B	7.28B	9.93B	13.46B
Total Assets	106B	109B	107B	117B	137B
Liabilities
Accounts Payable, Total	6.39B	5.04B	4.97B	5B	4.52B
Accrued Expenses, Total	11.49B	12.63B	14.19B	13.87B	13.74B
Short-term Borrowings	112M	246M	72M	149M	289M
Current Portion of Long-Term Debt	2.3B	1.7B	1.3B	2.5B	2.3B
Current Portion of Leases	304M	281M	285M	282M	294M
Current Income Taxes Payable	1.22B	1.99B	2.65B	3.91B	4.73B
Other Current Liabilities	2.05B	2.36B	2.23B	2.71B	2.46B
Total Current Liabilities	23.87B	24.24B	25.69B	28.42B	28.33B
Long-Term Debt	30.69B	28.74B	33.68B	34.46B	46.75B
Long-Term Leases	1.22B	1.01B	928M	877M	901M
Pension & Other Post Retirement Benefits	1.87B	1.22B	1.23B	939M	839M
Deferred Tax Liability Non Current	3.44B	1.8B	871M	1.39B	1.44B
Other Non Current Liabilities	6.34B	6.09B	6.63B	4.65B	5.95B
Total Liabilities	67.44B	63.1B	69.04B	70.73B	84.2B
Common Stock, Total	1.79B	1.79B	1.79B	1.79B	1.79B
Additional Paid In Capital	44.24B	44.38B	44.51B	44.7B	45.03B
Retained Earnings	53.7B	61.08B	53.9B	63.07B	73.08B
Treasury Stock	-57.11B	-56.49B	-57.45B	-58.3B	-63B
Comprehensive Income and Other	-4.43B	-4.77B	-5.16B	-4.94B	-4.29B
Total Common Equity	38.18B	45.99B	37.58B	46.31B	52.61B
Minority Interest	73M	67M	54M	59M	56M
Total Equity	38.26B	46.06B	37.64B	46.37B	52.66B
Total Liabilities And Equity	106B	109B	107B	117B	137B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.53B	2.54B	2.53B	2.53B	2.47B
ECS Total Common Shares Outstanding	2.53B	2.54B	2.53B	2.53B	2.47B
Book Value / Share	15.11	18.12	14.84	18.32	21.26
Tangible Book Value	-6.01B	4.52B	-1.63B	8.28B	4.35B
Tangible Book Value Per Share	-2.38	1.78	-0.64	3.27	1.76
Total Debt	34.63B	31.98B	36.27B	38.27B	50.53B
Net Debt	26.52B	18.79B	29.18B	24.58B	35.97B
Debt Equivalent of Unfunded Proj. Benefit Obligation	312M	42M	122M	-939M	-2.59B
Debt Equivalent Oper. Leases	2.74B	2.67B	2.71B	2.78B	3.38B
Minority Interest, Total (Incl. Fin. Div)	73M	67M	54M	59M	56M
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	4	4	4	4	4
LIFO Reserve, Total	-16M	-293M	-562M	-840M	-912M
Inventories - Raw Materials, Total	4.03B	4.12B	4.69B	4.64B	4.96B
Inventories - Finished Goods, Total	1.75B	1.84B	1.95B	2.02B	2.28B
Inventories - Others	196M	238M	277M	289M	331M
Land - (BS)	326M	295M	326M	307M	321M
Buildings, Total	12.53B	13.17B	14.97B	16.36B	17.98B
Machinery, Total	16.3B	16.76B	17.76B	18.28B	19.76B
Full Time Employees	67K	67K	70K	73K	73K
Part Time Employees	1K	2K	2K	2K	2K
Accumulated Allowance for Doubtful Accounts (Supple)	62M	72M	88M	89M	97M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	13.05B	14.52B	365M	17.12B	18.25B
Depreciation & Amortization - CF	1.49B	1.7B	1.69B	1.85B	1.84B
Amortization of Goodwill and Intangible Assets - (CF)	1.64B	2.08B	2.04B	2.4B	2.79B
Depreciation & Amortization, Total	3.12B	3.79B	3.73B	4.24B	4.64B
Asset Writedown & Restructuring Costs	393M	1.87B	932M	293M	1.26B
(Income) Loss On Equity Investments - (CF)	-1.94B	1.42B	-340M	-14M	-368M
Stock-Based Compensation (CF)	479M	541M	645M	761M	820M
Net Cash From Discontinued Operations	987M	-	-	-	-
Other Operating Activities, Total	1.86B	-260M	9.88B	2.73B	-1.15B
Change In Accounts Receivable	-2.03B	-644M	-1.15B	-244M	-1.09B
Change In Inventories	-674M	-161M	-816M	-835M	-1.18B
Change In Accounts Payable	405M	-289M	-380M	182M	110M
Change In Income Taxes	-540M	380M	214M	1.02B	137M
Change in Other Net Operating Assets	-997M	-2.07B	-75M	-3.79B	-4.95B
Cash from Operations	14.11B	19.1B	13.01B	21.47B	16.47B
Capital Expenditure	-4.45B	-4.39B	-3.86B	-3.37B	-4.11B
Cash Acquisitions	-12.91B	-121M	-12.03B	-4.09B	-10.04B
Investment in Marketable and Equity Securities, Total	1.02B	-483M	1.85B	-142M	471M
Other Investing Activities, Total	-225M	32M	-36M	-127M	-58M
Cash from Investing	-16.56B	-4.96B	-14.08B	-7.73B	-13.74B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	7.94B	-	5.94B	3.6B	13.88B
Total Debt Issued	7.94B	-	5.94B	3.6B	13.88B
Short Term Debt Repaid, Total	-3.99B	-	-	-	-
Long-Term Debt Repaid, Total	-2.32B	-2.25B	-1.76B	-1.29B	-2.5B
Total Debt Repaid	-6.3B	-2.25B	-1.76B	-1.29B	-2.5B
Issuance of Common Stock	202M	384M	125M	177M	92M
Repurchase of Common Stock	-840M	-	-1.35B	-1.31B	-5.08B
Common Dividends Paid	-6.61B	-7.01B	-7.44B	-7.84B	-8.18B
Common & Preferred Stock Dividends Paid	-6.61B	-7.01B	-7.44B	-7.84B	-8.18B
Other Financing Activities, Total	8.21B	-240M	-328M	-372M	-131M
Cash from Financing	2.59B	-9.12B	-4.81B	-7.03B	-1.92B
Foreign Exchange Rate Adjustments	-133M	-410M	23M	-293M	563M
Net Change in Cash	14M	4.61B	-5.86B	6.41B	1.37B
Supplemental Items
Cash Interest Paid	779M	937M	1.1B	1.3B	1.3B
Cash Income Tax Paid (Refund)	2.4B	3.2B	4.34B	3.93B	6.09B
Levered Free Cash Flow	6.67B	12.69B	9.26B	17.83B	11.89B
Unlevered Free Cash Flow	7.17B	13.29B	9.98B	18.62B	12.73B
Change In Net Working Capital	1.89B	-496M	520M	-1.43B	3.9B
Net Debt Issued / Repaid	1.63B	-2.25B	4.18B	2.31B	11.38B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	10.05	11.96	9.25	13.9	12.04
Return on Total Capital	15.05	17.03	13.14	19.62	16.28
Return On Equity %	38.82	34.46	0.9	40.79	36.88
Return on Common Equity	38.88	34.5	0.87	40.81	36.91
Margin Analysis
Gross Profit Margin %	72.81	70.98	73.53	77.09	77.21
SG&A Margin	19.31	16.31	16.44	15.74	15.56
EBITDA Margin %	38.97	41.08	32.78	45.4	44.77
EBITA Margin %	35.92	38.21	29.97	42.52	41.93
EBIT Margin %	32.56	34.69	26.57	38.79	37.64
Income From Continuing Operations Margin %	25.37	24.5	0.63	26.7	28.09
Net Income Margin %	26.79	24.49	0.61	26.68	28.08
Net Avail. For Common Margin %	25.35	24.49	0.61	26.68	28.08
Normalized Net Income Margin	19.28	21.29	15.83	23.44	22.42
Levered Free Cash Flow Margin	13.69	21.41	15.41	27.79	18.28
Unlevered Free Cash Flow Margin	14.73	22.42	16.6	29.02	19.59
Asset Turnover
Asset Turnover	0.49	0.55	0.56	0.57	0.51
Fixed Assets Turnover	2.46	2.72	2.54	2.59	2.5
Receivables Turnover (Average Receivables)	5.41	5.54	5.39	5.78	5.46
Inventory Turnover (Average Inventory)	2.3	2.9	2.59	2.36	2.32
Short Term Liquidity
Current Ratio	1.27	1.47	1.25	1.36	1.54
Quick Ratio	0.79	0.98	0.73	0.87	0.96
Operating Cash Flow to Current Liabilities	0.59	0.79	0.51	0.76	0.58
Days Sales Outstanding (Average Receivables)	67.52	65.88	67.78	63.29	66.84
Days Outstanding Inventory (Average Inventory)	158.6	125.84	140.69	155.22	157.27
Average Days Payable Outstanding	147.9	121.49	112.98	119.47	113.01
Cash Conversion Cycle (Average Days)	78.22	70.23	95.49	99.04	111.1
Long Term Solvency
Total Debt/Equity	90.52	69.44	96.37	82.53	95.96
Total Debt / Total Capital	47.51	40.98	49.08	45.21	48.97
LT Debt/Equity	83.42	64.61	91.96	76.21	90.48
Long-Term Debt / Total Capital	43.79	38.13	46.83	41.75	46.18
Total Liabilities / Total Assets	63.8	57.81	64.72	60.4	61.52
EBIT / Interest Expense	19.67	21.38	13.94	19.58	18.03
EBITDA / Interest Expense	23.97	25.66	17.49	23.2	21.76
(EBITDA - Capex) / Interest Expense	18.46	21.1	14.12	20.54	18.73
Total Debt / EBITDA	1.79	1.3	1.81	1.3	1.71
Net Debt / EBITDA	1.37	0.76	1.46	0.83	1.22
Total Debt / (EBITDA - Capex)	2.33	1.58	2.24	1.47	1.99
Net Debt / (EBITDA - Capex)	1.78	0.93	1.8	0.94	1.42
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	17.31	21.72	1.4	6.74	1.31
Gross Profit, 1 Yr. Growth %	18.36	19.53	5.05	11.92	1.47
EBITDA, 1 Yr. Growth %	31.26	31.13	-18.84	47.84	-0.1
EBITA, 1 Yr. Growth %	33.95	32.57	-20.19	51.43	-0.09
EBIT, 1 Yr. Growth %	41.05	33.12	-22.04	55.81	-1.7
Earnings From Cont. Operations, 1 Yr. Growth %	173.23	17.54	-97.4	4.44K	6.6
Net Income, 1 Yr. Growth %	84.65	11.27	-97.49	4.59K	6.64
Normalized Net Income, 1 Yr. Growth %	43.8	38.14	-24.33	58.12	-3.12
Diluted EPS Before Extra, 1 Yr. Growth %	173.03	17.49	-97.55	4.71K	8.01
Accounts Receivable, 1 Yr. Growth %	48.88	-1.47	10.2	0.42	14.14
Inventory, 1 Yr. Growth %	7.18	-0.71	7.56	-3.92	8.99
Net Property, Plant and Equip., 1 Yr. Growth %	11.65	9.12	7.55	2.7	6.66
Total Assets, 1 Yr. Growth %	15.4	3.28	-2.28	9.78	16.87
Tangible Book Value, 1 Yr. Growth %	-21.56	-175.14	-136.01	-608.6	-47.48
Common Equity, 1 Yr. Growth %	50.82	20.45	-18.29	23.24	13.59
Cash From Operations, 1 Yr. Growth %	37.77	35.34	-31.89	65.06	-23.27
Capital Expenditures, 1 Yr. Growth %	0.43	-1.35	-11.96	-12.71	21.95
Levered Free Cash Flow, 1 Yr. Growth %	26.09	98.28	-26.75	92.51	-33.33
Unlevered Free Cash Flow, 1 Yr. Growth %	23.49	92.52	-24.66	86.65	-31.62
Dividend Per Share, 1 Yr. Growth %	6.56	6.15	5.8	5.48	5.19
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	11.58	19.49	11.1	4.04	3.99
Gross Profit, 2 Yr. CAGR %	12.42	19.37	12	8.43	6.57
EBITDA, 2 Yr. CAGR %	17.64	33.75	7.61	9.54	21.53
EBITA, 2 Yr. CAGR %	19.1	36.19	7.72	9.94	23
EBIT, 2 Yr. CAGR %	22.09	40.65	7.23	10.21	23.76
Earnings From Cont. Operations, 2 Yr. CAGR %	48.47	79.21	-82.53	8.6	596.01
Net Income, 2 Yr. CAGR %	15.14	43.33	-83.28	8.58	607.18
Normalized Net Income, 2 Yr. CAGR %	22.03	45.02	7.96	9.38	23.76
Diluted EPS Before Extra, 2 Yr. CAGR %	48.29	79.11	-83.03	8.65	621.11
Accounts Receivable, 2 Yr. CAGR %	23.17	21.12	4.2	2.32	7.06
Inventory, 2 Yr. CAGR %	-0.21	3.16	3.35	1.66	2.33
Net Property, Plant and Equip., 2 Yr. CAGR %	13.75	10.38	8.33	5.1	4.66
Total Assets, 2 Yr. CAGR %	11.91	9.17	0.46	3.58	13.27
Tangible Book Value, 2 Yr. CAGR %	-11.71	-23.23	-47.98	35.34	63.44
Common Equity, 2 Yr. CAGR %	21.4	34.78	-0.79	0.35	18.31
Cash From Operations, 2 Yr. CAGR %	2.46	36.55	-3.99	6.03	12.54
Capital Expenditures, 2 Yr. CAGR %	14.9	-0.46	-6.81	-12.34	3.17
Levered Free Cash Flow, 2 Yr. CAGR %	-6.57	63.29	30.63	18.75	13.29
Unlevered Free Cash Flow, 2 Yr. CAGR %	-6.46	58.68	29.7	18.58	12.97
Dividend Per Share, 2 Yr. CAGR %	8.71	6.36	5.98	5.64	5.34
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	4.82	14.86	13.13	9.63	3.12
Gross Profit, 3 Yr. CAGR %	7.01	14.46	14.39	11.97	6.06
EBITDA, 3 Yr. CAGR %	9.08	21.09	13.12	19.63	6.23
EBITA, 3 Yr. CAGR %	9.83	22.46	13.84	20.67	6.49
EBIT, 3 Yr. CAGR %	16.22	24.57	15.4	21.45	6.09
Earnings From Cont. Operations, 3 Yr. CAGR %	25.9	37.35	-56.32	11.51	7.93
Net Income, 3 Yr. CAGR %	28.02	13.83	-62.76	9.47	7.93
Normalized Net Income, 3 Yr. CAGR %	15.78	26.02	16.61	22.6	5.04
Diluted EPS Before Extra, 3 Yr. CAGR %	27.95	37.22	-57.15	11.52	8.43
Accounts Receivable, 3 Yr. CAGR %	14.26	14.34	17.36	1.04	6.12
Inventory, 3 Yr. CAGR %	3.05	-0.38	4.61	0.87	4.05
Net Property, Plant and Equip., 3 Yr. CAGR %	16.22	12.18	9.43	6.42	5.62
Total Assets, 3 Yr. CAGR %	8.55	8.95	5.21	3.48	7.83
Tangible Book Value, 3 Yr. CAGR %	8.9	-16.33	-40.35	11.23	-1.29
Common Equity, 3 Yr. CAGR %	12.66	21.08	14.07	6.64	4.58
Cash From Operations, 3 Yr. CAGR %	8.91	12.42	8.29	15.02	-4.81
Capital Expenditures, 3 Yr. CAGR %	19.37	9.21	-4.46	-8.82	-2.14
Levered Free Cash Flow, 3 Yr. CAGR %	-8.43	18.43	24.85	48.66	-2.04
Unlevered Free Cash Flow, 3 Yr. CAGR %	-7.86	17.48	23.64	46.43	-1.3
Dividend Per Share, 3 Yr. CAGR %	10.63	7.85	6.17	5.81	5.49
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.12	8.12	7.29	10.4	9.38
Gross Profit, 5 Yr. CAGR %	6.16	8.95	8.84	12.01	11.2
EBITDA, 5 Yr. CAGR %	4.38	14.06	6.15	16.26	16.41
EBITA, 5 Yr. CAGR %	4.75	15.12	6.41	17.21	17.42
EBIT, 5 Yr. CAGR %	9.5	20.78	9.6	18.53	18.67
Earnings From Cont. Operations, 5 Yr. CAGR %	25.68	43.13	-42.87	25.04	32.2
Net Income, 5 Yr. CAGR %	27.19	43.4	-43.28	11.7	20.9
Normalized Net Income, 5 Yr. CAGR %	9.18	20.99	9.47	18.99	19.42
Diluted EPS Before Extra, 5 Yr. CAGR %	28.08	45.69	-42.97	24.98	32.54
Accounts Receivable, 5 Yr. CAGR %	8.96	8.95	10.13	9.37	11.88
Inventory, 5 Yr. CAGR %	4.11	3.01	3.17	0.43	3.69
Net Property, Plant and Equip., 5 Yr. CAGR %	11.65	12.85	13	9.29	7.5
Total Assets, 5 Yr. CAGR %	2.08	4.43	5.24	6.77	8.37
Tangible Book Value, 5 Yr. CAGR %	5.41	19.31	-18.96	1.41	-10.73
Common Equity, 5 Yr. CAGR %	-0.97	6.02	7.08	12.32	15.75
Cash From Operations, 5 Yr. CAGR %	6.34	24.24	3.55	9.82	9.97
Capital Expenditures, 5 Yr. CAGR %	22.48	18.37	8.12	0.02	-1.47
Levered Free Cash Flow, 5 Yr. CAGR %	-7.53	14.34	1.29	18.47	20.09
Unlevered Free Cash Flow, 5 Yr. CAGR %	-6.97	13.8	1.71	17.83	19.26
Dividend Per Share, 5 Yr. CAGR %	7.16	7.98	8.75	6.96	5.84